SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-013475
Filing Date
2024-05-17
Accepted
2024-05-17 16:12:54
Documents
2
Period of Report
2024-05-07

Document Format Files

Seq Description Document Type Size
1 form3-05172024_080541.html 3  
1 form3-05172024_080541.xml 3 1685
2 ex24-05172024_080544.htm EX-24 7254
  Complete submission text file 0001415889-24-013475.txt   10445
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AXCELLA HEALTH INC. 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Leggett Thomas (Reporting) CIK: 0001774690 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38938 | Film No.: 24959805